Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stieber

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Clinical Biochemistry|July 6, 2004
Apoptotic markers in cancerS Holdenrieder, P Stieber
Deutsche Medizinische Wochenschrift (1946)|December 14, 2004
[Tumour markers--case report]R Lamerz, P Stieber
Deutsche Medizinische Wochenschrift (1946)|December 14, 2004
[Tumour markers]R Lamerz, P Stieber
MMW Fortschritte Der Medizin|December 12, 2002
[Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense]R Lamerz, P Stieber
Annals of the New York Academy of Sciences|July 15, 2004
Therapy control in oncology by circulating nucleosomesS Holdenrieder, P Stieber
Fortschritte Der Medizin|February 28, 1996
[Criteria for the use of tumor markers. 1: Quality assurance--characteristics of the most important tumor markers]A Fateh-Moghadam, P Stieber
Fortschritte Der Medizin|March 30, 1996
[Criteria for using tumor markers. 3: Indications and interpretation]A Fateh-Moghadam, P Stieber
MMW Fortschritte Der Medizin|June 17, 2005
[Tumor markers--how they should be applied]P Stieber, V Heinemann, A Schalhorn
Fortschritte Der Medizin|March 10, 1996
[Criteria for using tumor markers. 2: Indications and interpretation]V A Fateh-Moghadam, P Stieber
Current Oncology (Toronto, Ont.)|February 14, 2012
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancerR Moro, J Gulyaeva-Tcherkassova, P Stieber
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Clinical Biochemistry|July 6, 2004
Apoptotic markers in cancerS Holdenrieder, P Stieber
Deutsche Medizinische Wochenschrift (1946)|December 14, 2004
[Tumour markers--case report]R Lamerz, P Stieber
Deutsche Medizinische Wochenschrift (1946)|December 14, 2004
[Tumour markers]R Lamerz, P Stieber
MMW Fortschritte Der Medizin|December 12, 2002
[Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense]R Lamerz, P Stieber
Annals of the New York Academy of Sciences|July 15, 2004
Therapy control in oncology by circulating nucleosomesS Holdenrieder, P Stieber
Fortschritte Der Medizin|February 28, 1996
[Criteria for the use of tumor markers. 1: Quality assurance--characteristics of the most important tumor markers]A Fateh-Moghadam, P Stieber
Fortschritte Der Medizin|March 30, 1996
[Criteria for using tumor markers. 3: Indications and interpretation]A Fateh-Moghadam, P Stieber
MMW Fortschritte Der Medizin|June 17, 2005
[Tumor markers--how they should be applied]P Stieber, V Heinemann, A Schalhorn
Fortschritte Der Medizin|March 10, 1996
[Criteria for using tumor markers. 2: Indications and interpretation]V A Fateh-Moghadam, P Stieber
Current Oncology (Toronto, Ont.)|February 14, 2012
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancerR Moro, J Gulyaeva-Tcherkassova, P Stieber
Pageof 9